NCT06029244View on ClinicalTrials.gov

Eyecontrol coMmunication Platform for dEliRium manaGemEnt in Intensive Care Units (EMERGE)

NARecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

February 25, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions
DeliriumDelirium in Old AgeCritical IllnessIntensive Care Unit Delirium
Interventions
DEVICE

EyeControl-Pro

Based on artificial intelligence (AI)-powered eye-tracking technology, the EyeControl-Pro wearable device and smart platform enable 24/7 customizable communication and monitoring between ventilated patients who cannot speak, their families, and medical teams

OTHER

Control

No intervention

Trial Locations (3)

02215

RECRUITING

Beth Israel Deaconess Medical Center, Boston

Unknown

NOT_YET_RECRUITING

Assuta Ashdod Medical Center, Ashdod

NOT_YET_RECRUITING

Rabin Medical Center, Petah Tikva

Sponsors

Collaborators (1)

Assuta Medical Center
All Listed Sponsors
collaborator

BIRD (Israel-United States Binational Industrial Research and Development) Foundation- Funding agency

UNKNOWN

collaborator

Rabin Medical Center

OTHER

collaborator

Assuta Medical Center

OTHER

collaborator

Eyefree Assisting Communication Ltd

INDUSTRY

lead

Beth Israel Deaconess Medical Center

OTHER

NCT06029244 - Eyecontrol coMmunication Platform for dEliRium manaGemEnt in Intensive Care Units (EMERGE) | Biotech Hunter | Biotech Hunter